Annual CFO
-$29.13 M
-$6.19 M-26.99%
December 31, 2022
Summary
- As of February 7, 2025, ARDS annual cash flow from operations is -$29.13 million, with the most recent change of -$6.19 million (-26.99%) on December 31, 2022.
- During the last 3 years, ARDS annual CFO has fallen by -$20.97 million (-256.99%).
- ARDS annual CFO is now -378.20% below its all-time high of -$6.09 million, reached on December 31, 2016.
Performance
ARDS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$983.00 K
+$3.36 M+77.37%
September 30, 2023
Summary
- As of February 7, 2025, ARDS quarterly cash flow from operations is -$983.00 thousand, with the most recent change of +$3.36 million (+77.37%) on September 30, 2023.
- Over the past year, ARDS quarterly CFO has increased by +$3.36 million (+77.37%).
- ARDS quarterly CFO is now -125.40% below its all-time high of $3.87 million, reached on September 30, 2019.
Performance
ARDS Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$17.89 M
+$3.28 M+15.51%
September 30, 2023
Summary
- As of February 7, 2025, ARDS TTM cash flow from operations is -$17.89 million, with the most recent change of +$3.28 million (+15.51%) on September 30, 2023.
- Over the past year, ARDS TTM CFO has increased by +$3.28 million (+15.51%).
- ARDS TTM CFO is now -692.42% below its all-time high of -$2.26 million, reached on June 30, 2020.
Performance
ARDS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ARDS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -27.0% | +77.4% | +15.5% |
| 3 y3 years | -257.0% | +82.4% | -52.7% |
| 5 y5 years | -65.9% | -125.4% | -119.2% |
ARDS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.0% | at low | at high | +90.3% | at high | +38.6% |
| 5 y | 5-year | -257.0% | at low | -126.8% | +90.3% | -692.4% | +38.6% |
| alltime | all time | -378.2% | at low | -125.4% | +90.3% | -692.4% | +38.9% |
Aridis Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$983.00 K(-77.4%) | -$17.89 M(-15.5%) |
| Jun 2023 | - | -$4.34 M(+8.5%) | -$21.17 M(-7.8%) |
| Mar 2023 | - | -$4.00 M(-53.2%) | -$22.96 M(-21.2%) |
| Dec 2022 | -$29.13 M(+27.0%) | -$8.56 M(+100.6%) | -$29.13 M(+19.9%) |
| Sep 2022 | - | -$4.26 M(-30.5%) | -$24.30 M(-15.1%) |
| Jun 2022 | - | -$6.14 M(-39.6%) | -$28.63 M(-1.6%) |
| Mar 2022 | - | -$10.17 M(+172.6%) | -$29.09 M(+26.9%) |
| Dec 2021 | -$22.94 M(+12.0%) | -$3.73 M(-56.6%) | -$22.94 M(-5.6%) |
| Sep 2021 | - | -$8.59 M(+30.1%) | -$24.30 M(+14.1%) |
| Jun 2021 | - | -$6.61 M(+64.9%) | -$21.29 M(+7.0%) |
| Mar 2021 | - | -$4.01 M(-21.4%) | -$19.91 M(-2.8%) |
| Dec 2020 | -$20.48 M | -$5.09 M(-8.8%) | -$20.48 M(+74.8%) |
| Sep 2020 | - | -$5.58 M(+6.9%) | -$11.71 M(+418.9%) |
| Jun 2020 | - | -$5.22 M(+14.2%) | -$2.26 M(-54.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$4.57 M(-224.6%) | -$4.92 M(-39.7%) |
| Dec 2019 | -$8.16 M(-66.4%) | $3.67 M(-5.2%) | -$8.16 M(-60.5%) |
| Sep 2019 | - | $3.87 M(-149.1%) | -$20.68 M(-29.3%) |
| Jun 2019 | - | -$7.88 M(+0.9%) | -$29.26 M(+5.8%) |
| Mar 2019 | - | -$7.81 M(-11.7%) | -$27.65 M(+13.9%) |
| Dec 2018 | -$24.27 M(+38.2%) | -$8.85 M(+87.7%) | -$24.27 M(+23.9%) |
| Sep 2018 | - | -$4.71 M(-24.8%) | -$19.58 M(+1.7%) |
| Jun 2018 | - | -$6.27 M(+41.3%) | -$19.26 M(+3.1%) |
| Mar 2018 | - | -$4.44 M(+6.6%) | -$18.69 M(+6.4%) |
| Dec 2017 | -$17.56 M(+188.2%) | -$4.16 M(-5.1%) | -$17.56 M(+31.1%) |
| Sep 2017 | - | -$4.39 M(-23.0%) | -$13.39 M(+48.7%) |
| Jun 2017 | - | -$5.70 M(+72.3%) | -$9.01 M(+172.3%) |
| Mar 2017 | - | -$3.31 M | -$3.31 M |
| Dec 2016 | -$6.09 M | - | - |
FAQ
- What is Aridis Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals annual CFO year-on-year change?
- What is Aridis Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly CFO year-on-year change?
- What is Aridis Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals TTM CFO year-on-year change?
What is Aridis Pharmaceuticals annual cash flow from operations?
The current annual CFO of ARDS is -$29.13 M
What is the all time high annual CFO for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual cash flow from operations is -$6.09 M
What is Aridis Pharmaceuticals annual CFO year-on-year change?
Over the past year, ARDS annual cash flow from operations has changed by -$6.19 M (-26.99%)
What is Aridis Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ARDS is -$983.00 K
What is the all time high quarterly CFO for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly cash flow from operations is $3.87 M
What is Aridis Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ARDS quarterly cash flow from operations has changed by +$3.36 M (+77.37%)
What is Aridis Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ARDS is -$17.89 M
What is the all time high TTM CFO for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high TTM cash flow from operations is -$2.26 M
What is Aridis Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ARDS TTM cash flow from operations has changed by +$3.28 M (+15.51%)